Myomo Inc Stock Analysis

Myomo Stock Analysis Notes

About 60.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.23. Myomo Inc last dividend was issued on the 31st of January 2020. The entity had 1:30 split on the 31st of January 2020. Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. Myomo operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 87 people. To find out more about Myomo Inc contact Paul Gudonis at 617 996 9058 or learn more at https://myomo.com.

Myomo Inc Investment Alerts

Myomo Inc Upcoming and Recent Events

Myomo Largest EPS Surprises

View All Earnings Estimates

Myomo Environmental, Social, and Governance (ESG) Scores

Myomo Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 170.84 M.

Myomo Profitablity

The company has Net Profit Margin of (0.33) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.1) %, which entails that for every $100 of revenue, it lost $0.1.

Management Efficiency

Myomo Inc has Return on Asset of (0.3145) % which means that on every $100 spent on assets, it lost $0.3145. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.8254) %, meaning that it generated no profit with money invested by stockholders. Myomo's management efficiency ratios could be used to measure how well Myomo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of March 2025, Return On Tangible Assets is likely to drop to -0.53. In addition to that, Return On Capital Employed is likely to drop to -0.85. At this time, Myomo's Net Tangible Assets are very stable compared to the past year. As of the 2nd of March 2025, Non Current Assets Total is likely to grow to about 1.1 M, while Total Assets are likely to drop about 10.4 M.

Technical Drivers

As of the 2nd of March, Myomo secures the Downside Deviation of 3.17, mean deviation of 2.61, and Risk Adjusted Performance of 0.0379. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Myomo Inc, as well as the relationship between them.

Myomo Inc Price Movement Analysis

Myomo Inc Insider Trading Activities

Myomo Outstanding Bonds

Myomo Predictive Daily Indicators

Myomo Corporate Filings

Myomo Forecast Models

Myomo's time-series forecasting models are one of many Myomo's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Myomo's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Myomo prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Myomo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Myomo. By using and applying Myomo Stock analysis, traders can create a robust methodology for identifying Myomo entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Myomo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Myomo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Myomo Inc stock analysis indicators help investors evaluate how Myomo stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Myomo shares will generate the highest return on investment. By understating and applying Myomo stock analysis, traders can identify Myomo position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.